57-year-old female patient with newly diagnosed cervical cancer. Evaluate for disease status. PELVIS:UTERUS, ADNEXA: There is a 5.3 x 3.6 x 3.5 (craniocaudal by AP by transverse) lesion within the cervix demonstrating low T2 signal and enhancement compatible with tumor (image 18, series 601 and image 16, series 801). The lesion extends into the posterior wall of the lower uterine body. There is parametrial invasion along the posterior wall of the cervix, more predominately along the left side extending to the mesorectal fascia. The mass protrudes into the vagina and may involve the upper third of the vaginal wall.There is a focus of susceptibility artifact within the lower anterior uterine body.There is a solid lesion within the right ovary measuring 5.1 x 3.2 cm with more focal hypointense T2 components. This lesion demonstrates progressive enhancement on postcontrast imaging. The left ovary is unremarkable.BLADDER: No significant abnormality noted.LYMPH NODES: There is a enlarged left common iliac station lymph node measuring 1.7 x 1.6 cm (image 362, series 1001), which is suspicious for metastatic adenopathy.BOWEL, MESENTERY: No significant abnormality noted.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.
1.Cervical mass compatible with cervical cancer with parametrial invasion.2.Solid right ovarian lesion is non-specific but may represent an ovarian metastasis or a fibrous tumor such as a fibroma, fibrothecoma, or Brenner's tumor given low T2 components.3.Enlarged left iliac station lymph node is suspicious for metastatic lymphadenopathy.